US Executive Compensation Proxy SEC Filings — April 30, 2026

30-04-2026

Contango ORE, Inc. completed its acquisition of Dolly Varden Silver Corporation on March 26, 2026, pursuant to an arrangement agreement dated December 7, 2025, issuing 13,686,278 shares of Common Stock, replacement options for 417,048 shares, and 1,597,301 Exchangeable Shares, resulting in former Dolly Varden shareholders owning approximately 50% of the economic and voting interest alongside existing Contango shareholders. This significant dilution of prior shareholders' ownership is disclosed in the DEF 14A proxy statement for the annual meeting, which also seeks votes on director elections, auditor ratification, and advisory approval of executive compensation. No financial performance metrics, growth, or declines are detailed in the filing excerpt.

• ·Eligible Canadian Dolly Varden shareholders could elect Exchangeable Shares for tax deferral purposes.
• ·All Dolly Varden RSUs converted to Dolly Varden Shares prior to exchange; Dolly Varden Options converted to Replacement Options.
• ·Proxy materials made available via Notice of Internet Availability on or about April 30, 2026.
• ·2025 Annual Report filed with SEC on March 16, 2026.

30-04-2026

Acacia Research Corporation (ACTG) filed its DEF 14A definitive proxy statement on April 30, 2026, for the virtual 2026 Annual Meeting of Stockholders on June 23, 2026, at 1:00 p.m. ET. Stockholders of record as of April 28, 2026, will vote on electing five directors to serve until the 2027 annual meeting, ratifying Grant Thornton LLP as independent auditors for the fiscal year ending December 31, 2026, and approving named executive officer compensation on a non-binding advisory basis. The proxy highlights the Board's structure, including separation of Chairman (Gavin Molinelli) and CEO (Martin D. McNulty, Jr.) roles, with Maureen O’Connell as Lead Independent Director.

• ·Virtual Annual Meeting accessible at www.virtualshareholdermeeting.com/ACTG2026 with 16-digit control number required.
• ·Proxy materials and Form 10-K for fiscal year ended December 31, 2025, available at https://www.acaciaresearch.com/proxy-materials and www.proxyvote.com.
• ·Board committees: Audit (Chair: Isaac T. Kohlberg), Compensation (Chair: Michelle Felman), Nominating/Governance & Sustainability (Chair: Maureen O’Connell).
• ·Proxy solicitation assistance via Saratoga Proxy Consulting LLC at (888) 368-0379 (stockholders) or (212) 257-1311 (banks/brokers).

30-04-2026

Femasys Inc. (FEMY) filed a DEF 14A proxy statement dated April 30, 2026, for its annual meeting of stockholders, outlining proxy solicitation procedures, stockholder proposal deadlines for the 2027 Annual Meeting, and corporate governance practices. The board consists of five directors, with four independent directors (Charles Larsen, Mr. Milnes, Mr. Eichenbaum, Mr. Uzialko), and all standing committees (Audit, Compensation, Nominating and Corporate Governance) are fully independent with defined responsibilities. No financial performance metrics are disclosed; the filing emphasizes strong governance frameworks without notable changes or issues.

• ·Stockholder proposals for inclusion in 2027 proxy must be received by Corporate Secretary no later than December 29, 2026.
• ·Notice of stockholder proposals for presentation at 2027 Annual Meeting: not earlier than February 24, 2027, and not later than March 26, 2027.
• ·Principal executive office: 3950 Johns Creek Court, Suite 100, Suwanee, GA 30024.
• ·Transfer agent contact: (844) 998-0339, shareholder@broadridge.com, P.O. Box 1342, Brentwood, NY 11717.
• ·Charles Larsen qualifies as audit committee financial expert.
• ·Fiscal year reference: ended December 31, 2025.

30-04-2026

MidCap Financial Investment Corporation issued a definitive proxy statement (DEF 14A) for its 2026 virtual Annual Meeting of Stockholders on June 18, 2026, at 10:00 a.m. ET, seeking stockholder approval for the election of two Class I Directors (to serve until the 2029 Annual Meeting) and ratification of Deloitte & Touche LLP as independent registered public accounting firm for the fiscal year ending December 31, 2026. The record date is April 22, 2026, with 82,372,628 shares of common stock outstanding entitled to vote. No financial performance metrics or period-over-period comparisons are provided in the filing.

• ·Meeting is virtual only at www.virtualshareholdermeeting.com/MFIC2026; no physical location.
• ·Quorum requires holders of a majority of shares entitled to vote on record date.
• ·Election of directors is non-routine (no broker discretionary voting); auditor ratification is routine.
• ·Directors elected by majority of votes cast for and affirmatively withheld.
• ·Annual Report on Form 10-K for fiscal year ended December 31, 2025, available via internet.
• ·Stockholder list available for examination 10 days prior to meeting at principal offices.

30-04-2026

Semnur Pharmaceuticals, Inc. is soliciting proxies for its 2026 Annual Meeting of Stockholders, to be held virtually on June 25, 2026, at 9:00 a.m. Pacific Time, with proposals including the election of Jay Chun, M.D., Ph.D. as a Class I director, ratification of Pipara & Co LLP as independent auditors for fiscal year ending December 31, 2026, and approval of the 2025 Equity Incentive Plan and 2025 Employee Stock Purchase Plan. As of the record date April 28, 2026, 230,209,142 shares of common stock and 5,423,606 shares of Series A Preferred Stock (entitled to 5,423,606 votes) were outstanding, requiring a quorum of at least 117,816,375 votes. The Board recommends voting 'FOR' all proposals; no other matters are known to be presented.

• ·Director election (Proposal 1) requires plurality of votes cast; abstentions and broker non-votes have no effect.
• ·Proposals 2, 3, and 4 require majority of votes cast (excluding abstentions); broker non-votes have no effect.
• ·Proxy materials and Form 10-K for fiscal year ended December 31, 2025, first mailed on or about May 4, 2026.
• ·Voting deadline for Internet: 11:59 p.m. Eastern Time on June 24, 2026.

30-04-2026

Grindr Inc.'s DEF 14A proxy statement discloses 2025 executive compensation, including significant equity grants and modifications such as $28,912,500 in Refresh RSUs to CEO George Arison and $10,862,400 in New Hire RSUs to new CFO John North, alongside cash bonus opportunities up to $1,500,000 for Arison. However, some Market Condition PSU modifications resulted in decreased fair values (e.g., noted in multiple footnotes as reductions from original grant dates), and former CFO Vandana Mehta-Krantz received $1,170,772 in transition payments upon her departure on October 1, 2025, including severance equivalent to 12 months base salary. Modifications to outstanding PSUs added alternative performance conditions like share price and adjusted EBITDA targets with extended deadlines up to 2030.

• ·John North commenced as CFO on October 1, 2025; prorated 2025 cash bonus opportunity target $21,875.
• ·Vandana Mehta-Krantz served as senior advisor until March 31, 2026; transition payments include $252,500 for advisor service, $303,000 FY2025 bonus equivalent, $74,712 pro-rated FY2026 bonus, $35,560 COBRA.
• ·Market Condition PSU modifications include reduced market cap threshold from $10B to $7.5B and deadlines like October 19, 2027, December 31, 2027, March 31, 2029, December 31, 2030.
• ·Safe Harbor true-up payments in 2025 for 2024: $18,650 for Austin Balance, $6,635 for Zachary Katz.

30-04-2026

ImmunityBio's 2026 Proxy Statement highlights strong 2025 performance with full-year net product revenue of approximately $113 million, up 700% YoY, and unit sales growth of 750%, driven by ANKTIVA's commercial success and expanded insurance coverage for over 240 million lives. Key regulatory milestones include UK MHRA approval in July 2025, EC conditional authorization in February 2026, and SFDA accelerated approval for lung cancer. The annual meeting on June 9, 2026, seeks election of nine directors and ratification of Deloitte & Touche LLP as auditors.

• ·Annual Meeting: June 9, 2026 at 10:30 a.m. Pacific Time via webcast at virtualshareholdermeeting.com/IBRX2026
• ·Record Date: April 13, 2026
• ·Proposals: Elect nine directors; Ratify Deloitte & Touche LLP for FY 2026 audit
• ·FDA approval of ANKTIVA: April 2024; UK MHRA: July 2025; EC: February 2026; SFDA lung cancer approval
• ·J-code J9028 implemented January 2025
• ·Median overall survival extended to 21 months in checkpoint-refractory NSCLC patients
• ·CAR-NK therapy: 100% disease control in Waldenström lymphoma (chemotherapy-free, outpatient)

30-04-2026

Trinity Capital Inc.'s DEF 14A proxy statement discloses 2025 executive compensation for its NEOs, with CEO Kyle Brown's total compensation at $3,498,220, down approximately 50% YoY from $6,972,944 due to no stock awards despite a bonus increase to $2,310,000 from $1,815,000. COO Gerald Harder's total compensation fell 24% YoY to $2,361,340 from $3,113,798, though his bonus rose to $1,320,000 from $715,000. All five NEOs received uniform option awards valued at $346,125 each on March 14, 2025, under the 2019 Long-Term Incentive Plan, and entered amended employment agreements enhancing severance benefits including change-in-control protections.

• ·All NEO unvested RSAs valued at closing price of $14.65/share as of Dec 31 2025; e.g., Kyle Brown $4,239,036 total unvested equity incentive potential in CIC.
• ·Options vest upon 90-day VWAP >= $23.75/share, then 25% on 3/14/2026 and remainder quarterly.
• ·NEO Agreements amended 3/14/2025 provide 24 months severance for CEO (36 months post-CIC), 12 months for others (24 months post-CIC), plus bonus and equity acceleration.
• ·2025 All Other Compensation includes aircraft use (e.g., CEO $61,253), 401(k) match $14,000 each, insurance $1,842 each.

30-04-2026

GigaCloud Technology Inc's DEF 14A proxy statement for the 2026 Annual Meeting on July 10, 2026 seeks ratification of Grant Thornton LLP as independent auditor for FY2026, after dismissing KPMG effective March 2, 2026 with no disagreements or reportable events during 2024-2025 audits. KPMG audit fees declined 6.8% YoY to $2.05M in 2025 from $2.2M in 2024, while audit-related fees increased to $50k from $0 but tax fees dropped to $0 from $139k. The virtual meeting is for shareholders of record as of April 28, 2026.

• ·KPMG's audit reports for fiscal years ended Dec 31, 2025 and 2024 contained no adverse opinions, qualifications, or modifications.
• ·No disagreements with KPMG on accounting principles, financial disclosures, auditing scope, or procedures through March 2, 2026.
• ·Annual Meeting conducted virtually via live audio webcast at meetnow.global/MQKSRYF.
• ·Notice of proxy materials mailing expected around May 28, 2026; 2025 Annual Report available at https://www.gigacloudtech.com/

30-04-2026

Steele Creek Capital Corp's DEF 14A proxy statement solicits votes for its 2026 Annual Meeting on July 1, 2026, to elect Glenn Duffy and William H. Gates as Class I directors until the 2029 annual meeting and to ratify Grant Thornton LLP as independent auditors for the fiscal year ending December 31, 2026. The record date is April 30, 2026, with 5,821,906 shares of common stock outstanding. The Board unanimously recommends voting FOR all proposals, with materials to be mailed around May 29, 2026.

• ·Annual Meeting held virtually via conference call: dial-in 1-929-256-6220, requiring meeting ID, passcode, and Control Number from proxy card.
• ·Annual Report on Form 10-K for year ended December 31, 2025, filed with SEC on March 25, 2026.
• ·Quorum requires holders of a majority of votes entitled to be cast.

30-04-2026

Armstrong World Industries, Inc. (AWI) issued its DEF 14A proxy statement for the 2026 Annual Shareholders' Meeting on June 11, 2026 (virtual), seeking approval to elect 9 director nominees, ratify KPMG LLP as independent auditors, approve the 2026 Directors Stock Unit Plan, and provide an advisory vote on executive compensation. The statement highlights strong 2025 performance including acquisitions in Architectural Specialties, addition of two new directors, and a smooth CEO succession with Mark A. Hershey succeeding Victor D. Grizzle as President and CEO effective April 1, 2026; Grizzle transitions to Executive Chair until December 31, 2026, while Roy W. Templin serves as Lead Independent Director until becoming Chair on January 1, 2027. No declines or flat metrics are disclosed.

• ·Record Date: April 16, 2026
• ·Annual Meeting: 11:00 a.m. Eastern Time, Thursday, June 11, 2026, virtual at www.virtualshareholdermeeting.com/AWI2026
• ·Victor D. Grizzle to serve as Executive Chair until December 31, 2026
• ·Roy W. Templin to become Chair of the Board effective January 1, 2027

30-04-2026

Aprea Therapeutics, Inc.'s DEF 14A proxy statement for the 2026 Annual Meeting on June 16, 2026 (virtual, record date April 21, 2026) proposes electing three Class I directors (Marc Duey, Richard Peters, M.D., Ph.D., Bernd R. Seizinger, M.D., Ph.D.), ratifying EisnerAmper LLP as independent auditors for fiscal 2026, authorizing a discretionary reverse stock split of common stock (1-for-3 to 1-for-8, fractional shares rounded up, no reduction in authorized shares), and advisory votes approving named executive officer compensation and say-on-pay frequency. The Board, consisting of 9 members (8 independent), recommends FOR all six proposals including potential adjournment for Proposal 3. As of the record date, 12,382,776 shares of common stock were outstanding.

• ·Annual Meeting voting standard for uncontested director elections: plurality.
• ·Reverse stock split ratio to be determined by Board in sole discretion (not less than 1-for-3, not more than 1-for-8), effective at Board's chosen time if at all.
• ·Proxy materials available at http://www.proxyvote.com and 2025 Annual Report on Form 10-K referenced.

30-04-2026

Build-A-Bear Workshop, Inc. filed its DEF 14A proxy statement for the 2026 Annual Meeting of Stockholders on June 11, 2026, at 10:00 a.m. CT, to elect three directors, ratify Ernst & Young LLP as independent auditors for fiscal 2026, and approve executive compensation on a non-binding advisory basis. The record date is April 14, 2026, with 12,580,479 shares of common stock outstanding, requiring a quorum of 6,290,240 votes; no financial performance metrics or period-over-period comparisons are detailed in the provided content.

• ·Annual Meeting location: World Bearquarters, 415 South 18th Street, St. Louis, MO 63103
• ·Voting deadline for Internet/telephone: 11:59 p.m. ET on June 10, 2026
• ·Fiscal year-end referenced: January 31, 2026
• ·Proxy materials available at www.edocumentview.com/bbw and www.buildabear.com

30-04-2026

Latch, Inc.'s DEF 14A proxy statement seeks stockholder ratification of BDO as independent auditor for fiscal 2026 and an advisory vote to approve 2025 named executive officer (NEO) compensation. Audit fees for the year ended December 31, 2024 totaled $882,000.15, with no audit-related, tax, or other fees incurred in 2024 or 2025. 2025 NEO total compensation included $976,340 for CEO David Lillis, $609,206 for CFO Jeff Mayfield, and $806,420 for Chief Strategy & Legal Officer Priyen Patel, reflecting new appointments mid-year with prorated amounts and no prior-year comparables for these executives.

• ·Unexercisable performance stock options granted to CEO David Lillis: 3,000,000 at $0.41 exercise price, expiring 8/11/34.
• ·Closing stock price on December 31, 2025: $0.15 per share.
• ·APS hourly rates: $1,140 for Jason Keyes and $1,115 for Marc Landy services (15% discount effective October 15, 2023).

30-04-2026

Q32 Bio Inc. (QTTB) has issued a proxy statement for its 2026 Annual Meeting of Stockholders, to be held virtually on June 12, 2026 at 8:30 a.m. ET, seeking approval to elect three Class II directors—Kathleen LaPorte, Jodie Morrison, and Arthur Tzianabos, Ph.D.—each for a three-year term until 2029; ratify Ernst & Young LLP as independent auditors for the fiscal year ending December 31, 2026; and provide a non-binding advisory approval of named executive officer compensation. The record date is April 15, 2026, with 15,629,463 shares of common stock outstanding entitled to vote. The Board unanimously recommends voting FOR all three proposals.

• ·Annual Meeting voting deadline: 11:59 p.m. ET on June 11, 2026 for telephone, internet, and QR code votes; mailed proxies by June 11, 2026.
• ·Proxy materials available via www.proxyvote.com; Notice of Internet Availability mailed on or about April 30, 2026.
• ·Virtual meeting access: www.virtualshareholdermeeting.com/QTTB2026 using 16-digit control number.

30-04-2026

Warner Bros. Discovery, Inc. (WBD) filed its DEF 14A proxy statement for the 2026 Annual Meeting of Stockholders on April 30, 2026, seeking election of 13 director nominees (92% or 12 of 13 independent, average independent tenure 5 years), ratification of PricewaterhouseCoopers LLP as independent auditors for fiscal 2026, and advisory approval of 2025 named executive officer compensation, while recommending against a stockholder proposal from the National Center for Public Policy Research. The Board emphasizes nominees' diverse skills and experience for oversight of strategy execution. No specific financial performance metrics or period-over-period changes are detailed in the filing.

• ·2026 Annual Meeting scheduled as virtual event beginning 9:45 a.m. ET on June 9, 2026 at www.virtualshareholdermeeting.com/WBD2026.
• ·Audit firm appointment for fiscal year ending December 31, 2026.
• ·Advisory vote on 2025 executive compensation.

30-04-2026

Rockwell Medical, Inc. (RMTI) DEF 14A proxy statement discloses 2025 stock option grants to NEOs Mark Strobeck (308,000 options at $1.07/share, fair value $249,732), Jesse Neri (195,000 options at $1.07/share, fair value $158,109), and Megan Timmins (195,000 options at $1.07/share, fair value $158,109), approved post-stockholder increase in equity plan shares, with stock price declining 3.85% following disclosure. The filing details executive stock ownership guidelines (CEO: 3x base salary), insider trading/anti-hedging/anti-pledging policies, and updated clawback policy. Termination provisions provide severance (1-1.5x salary + benefits) and equity acceleration for CEO and other NEOs upon without cause/Good Reason or change in control.

• ·Stock ownership guidelines require CEO to hold shares worth 3x base salary by fifth anniversary.
• ·Clawback policy applies to incentive compensation received on/after Oct 2, 2023, recoverable post-restatement.
• ·Anti-hedging/anti-pledging prohibits directors/execs from pledging shares or hedging transactions.

30-04-2026

Lexeo Therapeutics, Inc. (LXEO) has filed its definitive proxy statement (DEF 14A) for the 2026 Annual Meeting of Stockholders, to be held virtually on June 25, 2026, at 10:00 a.m. ET, with stockholders of record as of May 7, 2026, entitled to vote. The meeting agenda includes electing three Class III directors—R. Nolan Townsend, Brenda Cooperstone, and Paula HJ Cholmondeley—to serve until the 2029 annual meeting, and ratifying KPMG LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026. As of April 24, 2026, there were 78,520,587 shares of common stock outstanding.

• ·Annual Meeting virtual access at www.virtualshareholdermeeting.com/LXEO2026
• ·Proxy materials and FY 2025 Annual Report available at ir.lexeotx.com
• ·Notice of Internet Availability mailed on or about May 12, 2026
• ·Proxies by Internet/telephone due by 11:59 p.m. ET on June 24, 2026

30-04-2026

Nexstar Media Group's 2026 Proxy Statement solicits votes for the June 16, 2026 annual meeting to elect nine directors, approve an advisory vote on NEO compensation, ratify PricewaterhouseCoopers LLP as auditors for 2026, and approve the 2026 Long-Term Omnibus Incentive Plan. The company highlights strong governance practices including a declassified board with 8 of 9 independent directors, 96% average board attendance in 2025, ongoing board refreshment with three new independents since 2021, and stockholder-friendly actions like updated stock ownership guidelines to 5x retainer and separation of Chair/CEO roles post-Sook. In 2025, Nexstar received 531 journalism awards and announced a landmark agreement to acquire TEGNA amid industry challenges.

• ·Record date for voting: April 20, 2026
• ·Annual meeting location: 545 E. John Carpenter Freeway, Suite 120, Irving, Texas 75062
• ·Board policy limits directors to 4 public company boards (2 if full-time officer)
• ·All directors in compliance with stock ownership guidelines as of December 31, 2025
• ·No off-cycle or one-time equity awards issued to senior executives in 2025

30-04-2026

Foghorn Therapeutics Inc. (FHTX) filed its DEF 14A proxy statement on April 30, 2026, for the virtual-only 2026 Annual Meeting of Stockholders on June 24, 2026, at 9 a.m. ET, with a record date of April 27, 2026, and 58,713,922 shares of common stock outstanding entitled to vote. Key proposals include the election of three Class III directors (Douglas Cole, M.D., Balkrishan (Simba) Gill, Ph.D., and B. Lynne Parshall), ratification of Deloitte & Touche LLP as independent auditors for the fiscal year ending December 31, 2026, advisory approval of named executive officer compensation, and a recommendation for annual say-on-pay frequency; the filing covers security ownership, pay versus performance, and related matters with no reported financial metrics or performance variances.

• ·Board recommends FOR all proposals: director elections, auditor ratification, Say on Pay approval, and 1 YEAR frequency for future Say on Pay votes.
• ·Annual Report on Form 10-K for year ended December 31, 2025 available at www.proxydocs.com/FHTX and SEC website.
• ·Company address: 99 Coolidge Avenue, Ste 500, Watertown, MA 02472.

30-04-2026

Unicycive Therapeutics, Inc. has filed a definitive proxy statement for its 2026 Annual Meeting of Stockholders on June 19, 2026, at 10:00 a.m. PDT in Mountain View, CA, to elect three members to the Board of Directors and ratify the appointment of Grassi & Co. CPAs, P.C. as independent registered public accounting firm for the fiscal year ending December 31, 2026. The record date is April 27, 2026, with 26,700,027 shares of common stock outstanding, requiring a quorum of 13,341,637 shares. No other matters are anticipated, and stockholders are urged to vote via internet, mail, or in person.

• ·Notice of Internet Availability of Proxy Materials mailed on or about May 7, 2026.
• ·Proxy materials available at https://annualgeneralmeetings.com/uncy2026.
• ·Alliance Advisors contact: 1-844-202-5703 (toll-free) or UNCY@allianceadvisors.com for voting assistance.
• ·Meeting attendance limited to stockholders with valid ID and proof of ownership as of record date; no cameras or recording devices permitted.

30-04-2026

OptimizeRx Corp (OPRX) has issued its DEF 14A proxy statement for the virtual Annual Meeting of Shareholders on June 9, 2026, at 10:00 AM EDT, with record date April 10, 2026, when 18,765,075 shares of common stock were outstanding. Proposals include electing seven director nominees, advisory approval of named executive officer compensation, amending the 2021 Equity Incentive Plan to add 1,000,000 shares (increasing total to 5,450,000 shares) and adopt an evergreen provision for annual increases, and ratifying Grant Thornton LLP as auditors for FY ending December 31, 2026. No financial performance metrics are discussed.

• ·Annual Meeting is virtual only via live audio webcast at www.virtualshareholdermeeting.com/OPRX2026; no physical location.
• ·Quorum requires holders of at least a majority of voting power of Common Stock.
• ·Proxy materials distributed starting April 30, 2026; includes Form 10-K for FY ended December 31, 2025 (not part of solicitation).

30-04-2026

QNB Corp.'s DEF 14A proxy statement for the June 9, 2026 Annual Meeting seeks shareholder votes to elect four Class II directors (including nominees Laurie A. Bergman and Randy S. Bimes), approve the QNB Corp. 2026 Employee Stock Purchase Plan, and ratify Baker Tilly US, LLP as the independent registered public accounting firm for 2026. The Board unanimously recommends voting FOR all proposals. As of the April 10, 2026 record date, there were 4,993,046 shares of common stock outstanding.

• ·Annual Meeting location: The Centennial Catering & Conference Center, 3350 Center Valley Parkway, Center Valley, Pennsylvania 18034, at 11:00 a.m. Eastern time
• ·Quorum requires majority of outstanding shares present in person or by proxy
• ·Director election by plurality vote; other proposals by majority of votes cast
• ·Shareholders of record as of April 10, 2026 entitled to vote

30-04-2026

Pyxis Oncology, Inc. (PYXS) has filed a DEF 14A proxy statement for its 2026 Annual Meeting of Stockholders on June 15, 2026, at 10:00 a.m. ET virtually, seeking election of three Class II directors—Thomas Civik, Freda Lewis-Hall, M.D., and Michael A. Metzger—and ratification of Ernst & Young LLP as independent auditors for the fiscal year ending December 31, 2026. The record date is April 20, 2026, with 62,855,464 shares of common stock outstanding. Stockholders are encouraged to vote via internet, telephone, mail, or virtually, with materials available at www.proxydocs.com/PYXS.

• ·Annual Meeting registration required at www.proxydocs.com/PYXS with control number from proxy card or Internet Notice
• ·Proposal One (director election) is non-routine; Proposal Two (auditor ratification) is routine, allowing broker discretionary voting
• ·Company's Annual Report on Form 10-K for fiscal year ended December 31, 2025 available at www.proxydocs.com/PYXS

30-04-2026

Thryv Holdings, Inc. (THRY) filed its 2026 Proxy Statement (DEF 14A) on April 30, 2026, outlining corporate governance practices, board composition, and committee structures. The seven-member Board has six independent directors, with Joseph A. Walsh as Chairman and CEO since December 2021 and John Slater as Lead Independent Director; all directors attended at least 75% of 2025 meetings, though Lauren Vaccarello missed the 2025 Annual Meeting. In 2025, the Board met 6 times, Audit Committee 4 times, Compensation Committee 6 times, and Nominating and Corporate Governance Committee 3 times.

• ·Audit Committee: Amer Akhtar (financial expert), John Slater (chair), Lauren Vaccarello.
• ·Compensation Committee: Bonnie Kintzer (chair), John Slater, Lauren Vaccarello.
• ·Nominating and Corporate Governance Committee: Amer Akhtar, Ryan O’Hara (chair), Lou Orfanos.
• ·Board oversees risks including cybersecurity, artificial intelligence, and others via Audit Committee and quarterly Governance, Risk, Ethics and Compliance Committee.

30-04-2026

Ridgepost Capital, Inc. (formerly referenced as P10, Inc., ticker PX) filed its DEF 14A definitive proxy statement dated April 30, 2026, for the Annual Meeting of Stockholders on June 18, 2026, seeking election of three directors for three-year terms, an advisory vote to approve named executive officer compensation, an advisory vote on say-on-pay frequency (Board recommends 1 year), and ratification of KPMG LLP as independent auditors for FY2026. As of the April 20, 2026 record date, 78,216,084 shares of Class A common stock (1 vote per share) and 31,260,504 shares of Class B common stock (10 votes per share) were outstanding, resulting in Class B holders controlling approximately 80% of the total 390,821,124 voting power; quorum requires a majority (~195 million votes). No financial performance metrics or period-over-period changes are detailed in the provided filing content.

• ·Annual Meeting location: offices of Herbert Smith Freehills Kramer, 1177 Avenue of the Americas, New York, New York 10036, at 9:00 a.m. local time
• ·Quorum threshold: majority of combined voting power (holders representing 195,410,563 votes)
• ·Stockholder list available for inspection starting June 8, 2026 at principal executive offices: 2699 Howell Street, Suite 1000, Dallas, Texas 75204
• ·Proxy materials available online at https://web.viewproxy.com/Ridgepost/2026 since April 30, 2026

30-04-2026

Norwegian Cruise Line Holdings Ltd. (NCLH) has issued its 2026 Proxy Statement for the Annual General Meeting on June 11, 2026, seeking shareholder approval for electing three Class I directors (Zillah Ellen Byng-Thorne, Alex Cruz, Linda P. Jojo), advisory approval of named executive officer compensation and a 1-year frequency for future say-on-pay votes, amendment to the 2013 Performance Incentive Plan to increase shares available for grants, ratification of PricewaterhouseCoopers LLP as independent auditors, while recommending against a shareholder proposal to declassify the board. The proxy highlights strong corporate governance practices including no hedging/pledging, robust clawback policy, and share ownership requirements, with no specific financial performance metrics or period-over-period comparisons provided in the summary. Board nominees bring diverse experience in aviation, consumer, and finance sectors.

• ·Record date for shareholders: April 15, 2026
• ·Meeting location: Pullman Miami, 5800 Waterford District Drive, Miami, Florida 33126, at 9:00 a.m. Eastern Time
• ·Proxy materials first available: April 30, 2026
• ·Class I director terms expire in 2029; Class II in 2027; Class III in 2028
• ·Shareholder proposal: Declassification of the Board of Directors (Proposal 6)

30-04-2026

Innventure, Inc. has issued a proxy statement for its 2026 Annual Meeting of Stockholders on June 17, 2026, at 10:00 a.m. ET virtually, with a record date of April 20, 2026. Stockholders will vote on electing three Class II directors—Bruce Brown, James O. Donnally, and Catriona Fallon—for three-year terms expiring in 2029, and ratifying Withum Smith+Brown, P.C. as the independent auditor for the fiscal year ending December 31, 2026. As of the record date, 82,094,894 shares of common stock, 35,792 shares of Series B Preferred Stock (0.97 votes each), and 159,270 shares of Series C Preferred Stock (1.3 votes each) are outstanding and entitled to vote as a single class.

• ·Annual Report on Form 10-K for year ended December 31, 2025 filed with SEC on March 30, 2026.
• ·Proxy materials available at www.proxyvote.com since April 30, 2026.
• ·Virtual meeting access at www.virtualshareholdermeeting.com/INV2026.

30-04-2026

Archer Aviation Inc.'s 2026 Proxy Statement outlines strong corporate governance, including a majority independent board (6 of 7 directors), fully independent committees, and executive compensation with maintained base salaries, milestone-tied bonuses, and balanced RSU/PSU equity awards. The annual shareholder meeting on June 26, 2026, proposes electing directors (reducing board size from 7 to 6 as Michael Spellacy is not renominated), approving redomestication to Texas, ratifying PwC as auditors, and an advisory vote on NEO pay. No performance declines noted, with all directors attending at least 75% of meetings.

• ·Record date: April 28, 2026
• ·Annual meeting: Friday, June 26, 2026 at 12:00 p.m. Pacific Time (virtual at www.virtualshareholdermeeting.com/ACHR2026)
• ·Proposals: (1) Election of directors (page 17), (2) Redomestication to Texas (page 24), (3) Ratify PwC for FY ending Dec 31, 2026 (page 54), (4) Advisory vote on NEO compensation (page 56)
• ·Board leadership: No chairperson; Fred M. Diaz as Lead Independent Director since Feb 2022
• ·All committees fully independent; Audit Committee financial expert: Maria Pinelli

30-04-2026

AMC Global Media Inc. (AMCX) filed its DEF 14A proxy statement on April 30, 2026, outlining board governance as a controlled company with Class B holders electing up to 75% of directors, resulting in 40% independent directors post-annual meeting. Independent directors include Matthew C. Blank, Joseph M. Cohen, Stephen C. Mills, Vincent Tese, Carl E. Vogel, and Debra G. Perelman; Kristin Dolan was appointed CEO and Class B Director in March 2026. The Board met 6 times in 2025 with all directors attending at least 75% of meetings and 12 of 13 attending the annual meeting.

• ·Company operates as a 'controlled company' under NASDAQ rules, exempt from majority independent board and nominating committee requirements.
• ·Audit Committee: Carl E. Vogel (Chair), Matthew C. Blank, Debra G. Perelman.
• ·Independent Compensation Committee in place.
• ·Dr. Leonard Tow served on Audit and Compensation Committees until August 10, 2025, and as Compensation Chair until June 5, 2025.
• ·Code of Conduct and Ethics available at http://investors.amcglobalmedia.com.
• ·Stockholder communications directed to Chairman of Audit Committee at 11 Penn Plaza, New York, NY 10001.

30-04-2026

Esquire Financial Holdings, Inc. filed a DEF 14A proxy statement for its Annual Meeting on May 28, 2026, proposing the election of four directors (three for three-year terms and one for a two-year term), ratification of Crowe LLP as independent auditors for the year ending December 31, 2026, and an advisory 'Say-on-Pay' vote on executive compensation. As of the record date of March 26, 2026, there were 8,637,034 shares of common stock outstanding, with directors and executive officers beneficially owning 1,207,556 shares (13.9%) in aggregate. Major 5% shareholders include Mawer Investment Management Ltd. (779,889 shares, 9.0%) and BlackRock, Inc. (525,653 shares, 6.1%).

• ·Record date for voting eligibility: March 26, 2026.
• ·Meeting location: 100 Jericho Quadrangle, Suite 100, Jericho, New York 11753.
• ·Conference call access for remote listening: 800-715-9871, conference code 5386343.
• ·2025 Annual Report on Form 10-K available at http://www.astproxyportal.com/ast/21569.

30-04-2026

Neonode Inc.'s DEF 14A proxy statement outlines the responsibilities of the Audit and Compensation, Nomination and Governance (CNG) Committees, director nomination processes including stockholder submission requirements 60-90 days prior to the annual meeting anniversary, and 2025 director cash compensation ranging from $7,825 to $28,169 with no stock awards or other compensation. The Board of Directors met 8 times in 2025, with each director attending at least 75% of meetings, though only one of four members attended the 2025 Annual Meeting. The CNG Committee did not retain a compensation consultant in 2025 or for 2026.

• ·Compensation converted at approximate weighted average exchange rate of 9.82 SEK to one USD for 2025.
• ·Bylaws amended and restated on March 8, 2023, to address SEC universal proxy rules (Rule 14a-19) and advance notice requirements.
• ·No directors held stock or option awards as of December 31, 2025.
• ·Stockholder director nominations must be submitted to Corporate Secretary at Karlavägen 100, 115 26 Stockholm, Sweden.

30-04-2026

Acrivon Therapeutics, Inc. (ACRV) has issued its DEF 14A Proxy Statement for the 2026 Annual Meeting of Stockholders on June 17, 2026, at 1:00 PM Eastern Time, held virtually at https://www.proxypush.com/ACRV. Stockholders are asked to elect two Class I director nominees, Michael Tomsicek, M.B.A. and Charles Baum, M.D., Ph.D., each for a three-year term ending in 2029, and to ratify PricewaterhouseCoopers LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026. The record date is April 23, 2026, with 42,801,353 shares of common stock outstanding and entitled to vote.

• ·Annual Meeting quorum requires holders of a majority of the voting power of outstanding shares present or by proxy.
• ·Proposal 1 (Director Election) requires plurality vote; Proposal 2 (Auditor Ratification) requires majority of votes cast.
• ·Proxy materials and 2025 Annual Report on Form 10-K available at www.proxydocs.com/ACRV.

30-04-2026

Sypris Solutions, Inc. issued a DEF 14A proxy statement dated April 30, 2026, for its 2026 Annual Meeting on June 16, 2026, soliciting votes for the election of two Class III directors (terms expiring 2029) and an advisory vote to approve named executive officer compensation. As of the record date April 27, 2026, 23,011,130 shares of common stock were outstanding, with the Gill family beneficially owning 9,250,490 shares (39.5%). The proxy includes sections on governance, director nominees, stock ownership, executive compensation tables for 2025, pay versus performance, and director compensation, with materials available at www.sypris.com/proxy-materials.

• ·Annual Meeting location: Residence Inn by Marriott, 401 Bullitt Lane, Rock Bridge Room, Louisville, Kentucky 40222, at 11:00 a.m. Eastern Time.
• ·Voting methods: in person, proxy card, telephone, or Internet (closes 12:01 a.m. ET on June 16, 2026).
• ·Quorum requires majority of outstanding shares present in person or by proxy.
• ·Class I directors terms expire 2027; Class II expire 2028.
• ·Proxy includes Summary Compensation Table, Outstanding Equity Awards at FYE 2025, Pay Versus Performance, and 2025 Director Compensation.

30-04-2026

Professional Diversity Network, Inc.'s DEF 14A proxy statement details 2025 executive compensation, with PEO Summary Compensation Table total rising 30.1% YoY to $356,120 from $273,600, while average non-PEO NEO SCT total fell 18.9% to $102,684 from $126,542. However, compensation actually paid declined for PEO by 6.4% to $256,120 and plummeted 58.4% for average non-PEO NEOs to $52,684, coinciding with net losses widening from $(2,511,965) to $(6,450,991) and TSR value dropping 76% from $25 to $6 on a $100 initial investment. The filing also covers director compensation, employment terms, outstanding equity awards, and Proposal 2 to ratify SR CPA & Co. as auditors for 2026.

• ·Adam He has 1,500 exercisable options at $44.60 expiring 3/11/2029; no outstanding equity awards for Wu, Gu, or Bozzuto as of Dec 31, 2025.
• ·Director 2025 total compensation: Cheung Wai Kee $30,198; Hao Zhang $32,666; others ranged $6,000-$29,765.
• ·Wu and Gu entitled to $100,000 FMV equity after 12-month service; no awards granted by Dec 31, 2025.
• ·He employment: up to 50% bonus on $250,000 base; Bozzuto resigned as Interim CFO June 6, 2025.

30-04-2026

OPKO Health, Inc.'s DEF 14A Proxy Statement discloses governance policies, including a related party transaction threshold of $120,000 requiring Audit Committee approval or ratification, with chair pre-approval up to $250,000, and strict prohibitions on hedging, pledging, short selling, and derivative transactions involving company securities without consent. The company outlines its ESG strategy overseen by an ESG Working Group, covering environmental responsibility (e.g., e-signing, cloud migration), social impact (inclusive workplace, health/safety compliance), and governance (Code of Business Conduct and Ethics, lead independent director). Non-employee directors receive a $30,000 annual cash retainer, initial options for 50,000 shares, 30,000 shares annually thereafter, plus $7,500 additional retainers for committee chairs and Compensation Committee members.

• ·Trading windows for directors, officers, and certain employees begin on the first full business day after earnings release and end two weeks prior to quarter-end.
• ·Related Party definition includes stockholders with >5% beneficial ownership.
• ·Compliance with CLIA, OSHA, good manufacturing practices, and good clinical practices for health and safety.

30-04-2026

The Oncology Institute, Inc. (TOIIW) filed a DEF 14A proxy statement dated April 30, 2026, for its annual meeting, proposing the election of eight incumbent director nominees—Brad Hively, Karen Johnson, Mohit Kaushal, Anne McGeorge, Mark Pacala, Mark Stolper, Kimberly Tzoumakas, and Daniel Virnich—each for a one-year term expiring at the 2027 annual meeting. The Board unanimously recommends voting 'FOR' all nominees, highlighting their extensive healthcare leadership experience with no reported controversies or oppositions. No financial performance metrics, compensation details, or other proposals are quantified in the filing excerpt.

• ·Nominees' ages: Brad Hively (47), Karen Johnson (65), Mohit Kaushal (47), Anne McGeorge (65), Mark Pacala (70), Mark Stolper (54), Kimberly Tzoumakas (58), Daniel Virnich (47).
• ·Director tenure: Brad Hively, Karen Johnson, Mohit Kaushal, Anne McGeorge since November 12, 2021; Mark Pacala since September 21, 2022; Daniel Virnich since June 13, 2024; Mark Stolper since January 2, 2026; Kimberly Tzoumakas since February 23, 2026.
• ·Company incorporated November 19, 2019; Business Combination with TOI Parent, Inc. closed November 12, 2021.

30-04-2026

Black Stone Minerals, L.P. issued a DEF 14A proxy statement dated April 30, 2026, for its virtual annual meeting of limited partners on June 11, 2026, at 12:00 p.m. Central Time, soliciting votes on electing directors to serve until the 2027 annual meeting, ratifying Deloitte as independent registered public accounting firm for the year ending December 31, 2026, and providing a non-binding advisory vote to approve 2025 named executive officer compensation. As of the record date April 13, 2026, there were 212,498,512 common units held by 352 record holders and 14,711,219 preferred units held by one holder (AP Basileia SPV, LLC, voting on an as-converted basis), for a total of 227,209,731 voting units. The Board recommends voting 'FOR' all proposals, with AP Basileia agreeing to follow Board recommendations.

• ·Annual Meeting to be held virtually via live webcast; registration at https://register.proxypush.com/BSM
• ·Proxy materials notice mailed on or about April 30, 2026
• ·Holders of 15% or more of units generally not entitled to vote, with exceptions
• ·General Partner and Partnership units not voted in director elections
• ·List of record holders available for inspection from April 30, 2026, at Houston office

30-04-2026

Heritage Insurance Holdings, Inc. (HRTG) filed its DEF 14A proxy statement for the 2026 Annual Meeting of Stockholders on June 10, 2026, seeking approval to elect six directors (including CEO Ernie Garateix and Chairman Richard Widdicombe), ratify Plante & Moran, PLLC as independent auditors for FY2026, approve executive compensation on an advisory basis ('Say on Pay'), and set the frequency of future say-on-pay votes to one year. The Board emphasizes strong governance practices, with over 75% independent directors and all committees fully independent, alongside fulfillment of 2025 strategic profitability initiatives such as achieving rate adequacy in over 90% of territories and re-opening profitable geographies. Proactive shareholder engagement occurred throughout 2025 to align executive compensation with shareholder interests.

• ·Record date for voting: April 16, 2026
• ·Annual meeting location: The Grand Hyatt Tampa, 2900 Bayport Drive, Tampa, Florida 33607 (in-person and virtual at meetnow.global/MLWAMA4)
• ·Directors elected annually for one-year terms
• ·Over 75% of directors independent; board committees entirely independent

30-04-2026

Annaly Capital Management's 2026 Proxy Statement highlights robust 2025 performance with $16.1B in permanent capital and $104.7B in total assets as of December 31, 2025, delivering 20.2% economic return, 12.5% dividend yield, and 1,180% total stockholder return since its 1997 IPO. The Board recommends voting for election of nine director nominees, advisory approval of executive compensation, and ratification of Ernst & Young LLP as auditors, while opposing a stockholder proposal for written consent rights. Strong governance includes 89% independent directors, annual elections, and robust stockholder engagement.

• ·#1 issuer ranking in Nonconforming Markets for 2024-2025 per Inside Nonconforming Markets (January 16, 2026 issue)
• ·#1 servicer transfers for Fannie Mae and Freddie Mac in 2025 based on eMBS data as of December 31, 2025 (excludes platform acquisitions)
• ·Financial services industry turnover rate estimated at 16% in 2025 per U.S. Bureau of Labor Statistics
• ·Board refreshment policy triggered at 15 years of service or age 73
• ·Stockholders representing 25% of votes may request special meeting
• ·Over 180 investor meetings since beginning of 2025, outreach to 100% of top 100 stockholders

30-04-2026

Ategrity Specialty Insurance Company Holdings issued a proxy statement for its 2026 Annual Meeting of Stockholders on June 9, 2026, at 11:00 a.m. ET virtually, to elect seven directors until the 2027 meeting and ratify Ernst & Young LLP as independent auditors for the fiscal year ending December 31, 2026. The record date is April 16, 2026, with 48,066,674 shares of common stock outstanding. No financial results or performance metrics are disclosed in the filing.

• ·Annual Meeting held virtually at www.virtualshareholdermeeting.com/ASIC2026.
• ·Quorum requires majority of voting power represented.
• ·Director election by plurality; auditor ratification by majority of votes cast.
• ·Proxy materials available electronically via www.proxyvote.com; printed copies available upon request.

30-04-2026

GrabAGun Digital Holdings Inc. filed its 2026 DEF 14A Proxy Statement for the virtual Annual Meeting on June 23, 2026, seeking shareholder approval to elect eight directors (reducing board size from nine, with five independent) and ratify Weaver and Tidwell, L.L.P. as auditors for FY 2026. The letter from Lead Independent Director Kelly Reisdorf highlights strong governance in the first public year post-July 2025 Business Combination, including $8.9 million share repurchase, HQ/fulfillment investments, and executive comp alignment via 2026 incentive metrics. No performance declines noted, emphasizing capital discipline and board oversight.

• ·Business Combination consummated July 15, 2025.
• ·Record Date: April 24, 2026.
• ·Annual Meeting virtual via www.proxydocs.com/PEW at 10:00 a.m. CT.
• ·Company address: 200 East Beltline Road, Suite 403, Coppell, Texas 75019.
• ·Fiscal year ends December 31.

30-04-2026

WidePoint Corp's DEF 14A proxy statement details its executive officers including CEO Jin Kang and four EVPs, with bios highlighting extensive experience such as Robert George's leadership in 32 M&A transactions totaling $3.4B. It discloses beneficial ownership based on 9,872,661 shares outstanding as of April 24, 2026, and 2025 executive compensation where financial targets (e.g., EPS, FCF $2.4M-$2.9M, DHS recompete) were not achieved, resulting in discretionary bonuses of only $29,500 per NEO (10% of target) based on leadership performance. A Long-Term Incentive Plan with a 500,000-share pool for 2023-2025 ties awards to revenue growth and Adjusted EBITDA as a percentage of revenue.

• ·2025 bonus metrics weighting: Earnings Per Share/Net Income (40%), Free Cash Flow (10%), DHS Recompete (40%), Individual/Leadership (10%)
• ·Bonus payout limited to 10% of target due to failure to meet threshold levels for financial and strategic metrics
• ·Long-Term Incentive Plan performance goals: revenue increase and Adjusted EBITDA as % of revenue over 2023-2025

30-04-2026

Burke & Herbert Financial Services Corp. (BHRB) has issued a proxy statement for its 2026 Annual Meeting of Shareholders on June 18, 2026, held virtually, where shareholders will vote on electing 14 directors to serve until 2027, ratifying Crowe LLP as independent auditors for fiscal year 2026, and two advisory votes on executive compensation and vote frequency. The record date is April 10, 2026, with 15,046,137 common shares outstanding entitled to vote. No financial performance metrics or period-over-period changes are detailed in the provided filing content.

• ·Annual Meeting voting instructions must be received by 11:59 p.m. ET on June 17, 2026
• ·Proxy materials made available or mailed on April 30, 2026
• ·Beneficial owners need legal proxy from broker by June 4, 2026, to attend and vote virtually
• ·Includes 2025 Annual Report with financials as of/for year ended December 31, 2025

30-04-2026

Clipper Realty Inc.'s DEF 14A Proxy Statement for the year ended December 31, 2025, outlines robust corporate governance practices, including board committee roles in risk oversight, a Code of Business Conduct and Ethics, Insider Trading Policy prohibiting hedging and short sales, and processes for director nominations and stockholder communications. While no Compensation Committee interlocks or insider participation issues were identified, there was a minor compliance lapse with several directors filing late Section 16(a) Forms 4 on April 21, 2025, for LTIP unit awards granted on March 12, 2025. The statement confirms timely compliance with equity grant timing practices and no delinquent Section 16 reports otherwise.

• ·Delinquent Section 16(a) Forms 4 filed by Messrs. D. Bistricer, Levinson, Verrone, Ivanhoe, Burger, Kreider, Lorber, Schwimmer, J.J. Bistricer, and Spolan on April 21, 2025, reporting LTIP unit awards on March 12, 2025.
• ·Stockholder director nominations must be received at least 120 days prior to the one-year anniversary of the prior year's proxy statement.
• ·Insider Trading Policy filed as Exhibit 19.1 to the 2025 Form 10-K.

30-04-2026

Alpha Pro Tech, Ltd. issued its DEF 14A Proxy Statement dated April 30, 2026, for the 2026 Annual Meeting of Shareholders on June 10, 2026, proposing the election of seven directors to serve until 2027, ratification of Tanner LLP as independent auditors for the year ending December 31, 2026, and an advisory 'Say-on-Pay' vote on named executive officer compensation. As of the record date April 13, 2026, 10,216,932 common shares were issued and outstanding out of 50,000,000 authorized shares, with one vote per share. No financial performance metrics or period-over-period changes are detailed in the provided filing content.

• ·Annual Meeting location: Microtel Inn & Suites, 180 Goulding Avenue, Aurora, Ontario, Canada L4G 3Z2, at 9:30 a.m. local time on June 10, 2026.
• ·Record date: April 13, 2026.
• ·Quorum requires majority of outstanding shares present in person or by proxy.
• ·Directors elected by plurality vote; other proposals by majority of votes cast.
• ·Proxy materials first sent on or about April 30, 2026; available online.

30-04-2026

M-tron Industries, Inc. (MPTI) filed its DEF 14A Proxy Statement on April 30, 2026, for the 2026 Annual Meeting of Stockholders on June 16, 2026, seeking approval for the election of seven director nominees, an advisory vote on executive compensation, approval of the Second Amended and Restated 2022 Incentive Plan, and ratification of PKF O'Connor Davies, LLP as independent auditor. The record date is April 27, 2026, with 4,321,003 shares outstanding. No financial performance metrics or period-over-period comparisons are detailed in the filing.

• ·Annual Meeting location: Hilton Garden Inn Winter Park, Ravaudage B Meeting Room, 1275 Lee Road, Winter Park, Florida 32789 at 9:00 a.m. Eastern Time.
• ·2025 Annual Report on Form 10-K filed with SEC on March 26, 2026.
• ·Proxy materials mailed to stockholders on or about April 30, 2026.

30-04-2026

Star Equity Holdings, Inc. filed a DEF 14A proxy statement for its annual stockholder meeting on May 27, 2026, seeking approval for the election of seven directors, an advisory vote on named executive officer compensation as disclosed for fiscal years 2025 and 2024, and ratification of Wolf & Company, P.C. as independent auditor for fiscal 2026. The record date is March 31, 2026, with 3,707,314 shares of common stock outstanding entitled to vote. The statement details board governance, director compensation, executive employment agreements, pay versus performance for 2023-2025, and equity compensation plans.

• ·Annual Meeting time: 10:00 A.M. local time at 53 Forest Avenue, Suite 101, Old Greenwich, Connecticut 06870
• ·Proxy materials first sent on or about April 30, 2026
• ·Voting quorum: majority of shares present in person or by proxy

30-04-2026

Chicago Atlantic BDC, Inc. (formerly Silver Spike Investment Corp.) has filed a definitive proxy statement for its virtual annual meeting on June 24, 2026, at 10:00 a.m. ET, seeking re-election of Class 2 directors Americo Da Corte and Tracey Brophy Warson (terms until 2029 annual meeting) and ratification of BDO USA, P.C. as independent auditor for FY ending December 31, 2026. The record date is April 27, 2026, with proxy materials available online via notice and access model starting around May 4, 2026. The Board unanimously recommends voting FOR all proposals; no financial performance metrics or changes are discussed.

• ·Virtual annual meeting webcast at www.virtualshareholdermeeting.com/LIEN2026
• ·Proxy voting deadline: 11:59 p.m. ET on June 23, 2026
• ·Notice of Internet Availability mailed on or about May 4, 2026
• ·Company address: 600 Madison Avenue, Suite 1800, New York, New York 10022

30-04-2026

Falcon’s Beyond Global, Inc. has issued a proxy statement for its 2026 Annual Meeting of Stockholders on June 9, 2026, at 10:00 a.m. ET in Orlando, FL, to elect two Class III director nominees and ratify KPMG LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026. The record date is April 13, 2026, with stockholders of record entitled to vote one share per Class A or Class B common stock share and on an as-converted basis for Series B Preferred Stock. No other matters are known to be presented, and proxy materials are available online.

• ·Quorum requires holders of a majority in voting power of Common Stock and Series B Preferred Stock (as-converted) present or represented by proxy.
• ·Internet voting closes at 11:59 p.m. ET on June 8, 2026; mailed proxies due by 5:30 p.m. ET on June 8, 2026.
• ·Director Election Proposal is non-routine (broker non-votes possible); Ratification Proposal is routine.